About this item:

135 Views | 84 Downloads

Author Notes:

Correspondence: Stephen F. Traynelis, strayne@emory.edu

Author contributions: M.J. McDaniel designed and performed experiments, performed analysis, and wrote the paper. K.K. Ogden designed and performed experiments, performed analysis, and wrote the paper.

S.A. Kell designed experiments, performed simulations, performed analysis, and wrote the paper. P.B. Burger designed experiments, performed simulations, performed analysis, and wrote the paper. D.C. Liotta designed experiments and wrote the paper. S.F. Traynelis designed experiments, performed analysis, and wrote the paper.

Disclosures: S.F. Traynelis is a primary investigator on research grants from Biogen and Janssen to Emory University School of Medicine; is a member of the Scientific Advisory Board for Sage Therapeutics, the GRIN2B Foundation, and the CureGRIN Foundation; is cofounder of NeurOp, Inc.; and receives royalties for software.

D.C. Liotta is a member of the Board of Directors for NeurOp, Inc. D.C. Liotta and S.F. Traynelis are coinventors of Emory-owned intellectual property that includes allosteric modulators of NMDA receptor function. P.B. Burger is a cofounder of Avicenna Biosciences, LLC.

Subjects:

Research Funding:

This work was supported by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (grants R01-NS036654 and R35-NS111619-01 to S.F. Traynelis and grant F31-NS106896 to M.J. McDaniel).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Physiology
  • Partial agonist action
  • De-novo mutations
  • Glutamate receptor
  • Intellectual disability
  • Extracellular vestibule
  • Subunit arrangement
  • Proton sensitivity
  • Crystal structures
  • Structural basis
  • Rare variants

NMDA receptor channel gating control by the pre-M1 helix

Tools:

Journal Title:

Journal of General Physiology

Volume:

Volume 152, Number 4

Publisher:

Type of Work:

Article | Final Publisher PDF

Abstract:

The NMDA receptor (NMDAR) is an ionotropic glutamate receptor formed from the tetrameric assembly of GluN1 and GluN2 subunits. Within the flexible linker between the agonist binding domain (ABD) and the M1 helix of the pore-forming transmembrane helical bundle lies a two-turn, extracellular pre-M1 helix positioned parallel to the plasma membrane and in van der Waals contact with the M3 helix thought to constitute the channel gate. The pre-M1 helix is tethered to the bilobed ABD, where agonist-induced conformational changes initiate activation. Additionally, it is a locus for de novo mutations associated with neurological disorders, is near other disease-associated de novo sites within the transmembrane domain, and is a structural determinant of subunit-selective modulators. To investigate the role of the pre-M1 helix in channel gating, we performed scanning mutagenesis across the GluN2A pre-M1 helix and recorded whole-cell macroscopic and single channel currents from HEK293 cell-attached patches. We identified two residues at which mutations perturb channel open probability, the mean open time, and the glutamate deactivation time course. We identified a subunit-specific network of aromatic amino acids located in and around the GluN2A pre-M1 helix to be important for gating. Based on these results, we are able to hypothesize about the role of the pre-M1 helix in other NMDAR subunits based on sequence and structure homology. Our results emphasize the role of the pre-M1 helix in channel gating, implicate the surrounding amino acid environment in this mechanism, and suggest unique subunit-specific contributions of pre-M1 helices to GluN1 and GluN2 gating.

Copyright information:

© 2020 McDaniel et al.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/).
Export to EndNote